Search

Your search keyword '"Lipids"' showing total 4 results
4 results on '"Lipids"'

1. Reducing cardiovascular risk: latest recommendations.

Subjects
*RISK assessment, *SERIAL publications, *ADRENOCORTICAL hormones, *ANTILIPEMIC agents, *BEHAVIOR modification, *CARDIOVASCULAR diseases, *HYPERLIPIDEMIA, *IMMUNOSUPPRESSIVE agents, *BODY mass index, *DISEASE management, *LIPIDS, *LIFE expectancy, *SMOKING, *CARDIOVASCULAR diseases risk factors, *AGE distribution, *EZETIMIBE, *PHYSICIAN practice patterns, *NURSING practice, *HEALTH behavior, *AUTOIMMUNE diseases, *STATINS (Cardiovascular agents), *DRUG prescribing, *ALCOHOLISM, *BLOOD pressure, *DIABETES
Abstract

The article focuses on the latest NICE guideline aimed at increasing the number of patients offered statins to reduce cardiovascular risk, discussing detection methods, initiating statin therapy, and optimizing treatment for both primary and secondary prevention of cardiovascular disease (CVD). It emphasizes the importance of systematic risk assessment using tools like QRISK3, baseline tests before initiating statin therapy, and considerations for treatment escalation.

Published
2024

2. Diabetic kidney disease: diagnosis and management in primary care: Early diagnosis of diabetic renal disease (DKD) helps primary care teams to identify patients with type 2 diabetes who are at particular risk of subsequent cardiovascular disease but there is evidence of room for improvement

Author

LEWIS, DR ROBERT

Subjects
*PROTEINURIA diagnosis, *ANTILIPEMIC agents, *CARDIOVASCULAR diseases risk factors, *CREATININE, *DIABETIC nephropathies, *GLOMERULAR filtration rate, *LIPIDS, *TYPE 2 diabetes, *PRIMARY health care, *QUALITY assurance, *REFERENCE values, *RISK assessment, *ALBUMINS, *EARLY diagnosis, *ATORVASTATIN, *SODIUM-glucose cotransporters, *DISEASE complications
Abstract

The article presents an interview with Consultant Nephrologist, Robert Lewis, on diagnosis of diabetic renal disease. Topics include how has diabetic kidney disease recognised and how differ from chronic kidney disease in people without diabete; and how has proteinuria reliably detected in practice.

Published
2020

3. New lipid targets at odds with international standards.

Author

BOSTOCK, BEVERLEY

Subjects
*DRUG therapy for hyperlipidemia, *CARDIOVASCULAR diseases risk factors, *ANTILIPEMIC agents, *LDL cholesterol, *MEDICAL protocols, *RISK assessment, *HEALTH behavior, *LIPIDS, *BEHAVIOR modification
Abstract

The article focuses on the latest NICE guideline on Cardiovascular disease (CVD) risk assessment and reduction, particularly concerning lipid management targets, which has sparked debate within the Primary Care Cardiovascular Society (PCCS) regarding its alignment with other guidelines and its potential impact on reducing cardiovascular events.

Published
2024

4. CVD Masterclass: A lifetime approach to the prevention of cardiovascular disease.

Author

Haws, Joanne M.

Subjects
*CARDIOVASCULAR disease prevention, *BEHAVIOR modification, *BLOOD pressure, *CARDIOVASCULAR diseases risk factors, *DIET, *EXERCISE, *HEALTH behavior, *INFLAMMATION, *LIPIDS, *MEDICAL office nursing, *MEDICAL protocols, *RISK assessment, *SMOKING, *WORLD Wide Web, *INFORMATION resources, *PHYSICAL activity
Abstract

The article discusses an approach by the Joint British Societies for reducing the burden of cardiovascular disease (CVD) in individuals by promoting a better understanding of risk, improving uptake of lifestyle improvements and improving uptake of preventive therapies. Topics discussed include the introduction of the concept of "lifetime risk" as the key change in the approach in assessing CVD risk and the development of a risk calculator using "QRISK Lifetime" as basis for risk assessment.

Published
2014

Catalog

Books, media, physical & digital resources
See catalog results